GreenLight Biosciences Holdings, PBC
GRNADelisted Jul 24, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001822691
GreenLight Biosciences Holdings, PBC was delisted on Jul 24, 2023; its insiders filed their last Form 4 on Jul 27, 2023; 48 institutions reported holding it in 13F filings for Q2 2023, worth $9.16M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in GreenLight Biosciences Holdings, PBC as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1
- +1 vs. Q3 2021
- Shares held
- 786.1K
- +786.1K vs. Q3 2021
- Total value
- $7.80M
- +$7.80M vs. Q3 2021
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 48 | $9.16M |
| Q1 2023 | 60 | $15.7M |
| Q4 2022 | 60 | $44.4M |
| Q3 2022 | 57 | $86.2M |
| Q2 2022 | 50 | $65.2M |
| Q1 2022 | 39 | $279.7M |
| Q4 2021 | 1 | $7.80M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding GreenLight Biosciences Holdings, PBC; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 786,134 | $7.80M | 0.02% | +786,134 | New |